# Ciprofloxacin and Dexamethasone

NDC: 0832-1430
Generic name: Ciprofloxacin Hydrochloride and Dexamethasone
Labeler / Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: AURICULAR (OTIC)
Marketing started: 20260106

FDA application: ANDA216487

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 3 mg/mL
- DEXAMETHASONE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0832-1430"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0832-1430
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c5994d1-01d1-493c-a6ae-94754cd59389